The Hormone Replacement Therapy (HRT) Market showcases a notable trajectory, commencing with a valuation of USD 15.88 billion in 2023 and anticipated to ascend to USD 25.32 billion by 2031. This growth projection signifies a steady compound annual growth rate (CAGR) of 6.01% over the forecast period from 2024 to 2031. Several factors contribute to this expansion, including an aging population, increasing awareness about hormonal imbalances, and advancements in hormone therapy formulations and delivery methods. Additionally, the rising prevalence of menopausal symptoms and hormone-related disorders further propels market growth. As healthcare providers emphasize personalized treatment approaches, the demand for hormone replacement therapy is expected to persist, driving innovation and market expansion in the years ahead.